Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...
GlobalData on MSN
GSK to file for approval of hep B drug on positive Phase III data
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...
The hepatitis B surface antibody test (HBsAb) detects antibodies in the blood to determine if someone is immune to the hepatitis B virus (HBV). A negative or nonreactive result means the individual is ...
Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface antigen ...
Zacks Investment Research on MSN
GSK's chronic hepatitis B drug meets goals in two late-stage studies
GSK plc GSK announced positive results from two phase III studies, B-Well 1 and B-Well 2, which evaluated its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback